Publication | Open Access
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
498
Citations
25
References
2022
Year
Sexual HealthPhase 3Treatment And PreventionHuman RetrovirusAntiviral TherapyHptn 084PharmacotherapyAntiviral DrugHivMedicineEpidemiologyWomen's Health
| Year | Citations | |
|---|---|---|
Page 1
Page 1